login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
SEELOS THERAPEUTICS INC (SEEL) Stock News
USA
-
Nasdaq
- NASDAQ:SEEL -
US81577F3073
-
Common Stock
1.28
USD
-1.17 (-47.76%)
Last: 10/15/2024, 8:00:02 PM
1.45
USD
+0.17 (+13.28%)
After Hours:
10/15/2024, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
SEEL Latest News, Press Relases and Analysis
All
Press Releases
6 months ago - By: Benzinga
- Mentions:
ATAI
CMPS
MNMD
CYBN
...
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
a year ago - By: Seelos Therapeutics, Inc.
Seelos Announces Second Postponement of its Annual Meeting of Stockholders
a year ago - By: Benzinga
- Mentions:
ERIC
WOLF
JNJ
CDNA
...
Nasdaq Down 150 Points; Johnson & Johnson Reports Better-Than-Expected Q3 Results
a year ago - By: BusinessInsider
SEEL Stock Earnings: Seelos Therapeutics Beats Revenue for Q2 2024
a year ago - By: Seelos Therapeutics, Inc.
Seelos Announces Postponement of its Annual Meeting of Stockholders
a year ago - By: InvestorPlace
SEEL Stock Earnings: Seelos Therapeutics Beats Revenue for Q2 2024
2 years ago - By: BusinessInsider
SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023
2 years ago - By: InvestorPlace
SEEL Stock Earnings: Seelos Therapeutics Beats EPS for Q4 2023
a year ago - By: InvestorPlace
- Mentions:
AP
VVPR
NAAS
SNGX
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
a year ago - By: InvestorPlace
- Mentions:
ATAI
CMPS
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
2 years ago - By: Seelos Therapeutics, Inc.
Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
2 years ago - By: InvestorPlace
SEEL Stock Earnings: Seelos Therapeutics Beats EPS, Beats Revenue for Q1 2024
2 years ago - By: Seelos Therapeutics, Inc.
Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
2 years ago - By: Seelos Therapeutics, Inc.
Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations
2 years ago - By: InvestorPlace
- Mentions:
INVO
VNDA
VIAO
CLNN
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Please enable JavaScript to continue using this application.